miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1
- Type
- Expression of concern
- Notice date
- 10/18/2022 0:00
- Journal
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.biopha.2022.113813
- Original paper DOI
- 10.1016/j.biopha.2018.07.024